Needham & Company Reiterates a 'Buy' on Biolase Technology (BLTI); Great Qtr of Domestic Sales Signals Continued Turnaround

Go back to Needham & Company Reiterates a 'Buy' on Biolase Technology (BLTI); Great Qtr of Domestic Sales Signals Continued Turnaround
Biolase Technology, Inc. (NASDAQ: BLTI) Delayed: 2.42 +0.06 (2.54%)
Previous Close $2.36    52 Week High $6.13 
Open $2.36    52 Week Low $2.14 
Day High $2.49    P/E N/A 
Day Low $2.36    EPS $-0.17 
Volume 80,153